Chlorophyllin

Chlorophyllin is a water-soluble, semi-synthetic derivative of chlorophyll in which the magnesium ion is replaced by copper or sodium, enhancing its stability and bioavailability. It primarily exerts its effects by binding to and neutralizing polycyclic aromatic hydrocarbons and aflatoxins, potentially reducing their absorption and mutagenic activity.

Origin & History

Chlorophyllin is a water-soluble derivative of chlorophyll, primarily obtained from green plants such as spinach or alfalfa. It is produced through solvent extraction and processing to remove the phytol tail, often chelated with copper to form a stable compound for food and biomedical uses.

Historical & Cultural Context

The research dossier does not provide historical or traditional medicine context for chlorophyllin. Its use appears to be more modern and industrial, focusing on its chemical properties.

Health Benefits

• Antioxidant properties: Suggested by its chemical stability and solubility, but not supported by specific human trials.
• Detoxification support: Popularly believed but not directly evidenced in the reviewed research.
• Potential anti-inflammatory effects: Implications exist but lack clinical trial backing.
• May aid in body odor reduction: Inferred from common uses, though not clinically validated.
• Suggested tumor protective effects: A hypothesis from its parent compounds, not supported by studies in the dossier.

How It Works

Chlorophyllin acts as an antimutagenic agent by forming tight molecular complexes with planar, lipophilic carcinogens such as aflatoxin B1 and benzo[a]pyrene, reducing their intestinal absorption and systemic bioavailability. It also scavenges reactive oxygen species (ROS) through its porphyrin ring structure, and may inhibit cytochrome P450 1A2 (CYP1A2)-mediated activation of procarcinogens into their DNA-damaging metabolites. Additionally, chlorophyllin has been shown to upregulate phase II detoxification enzymes, including glutathione S-transferase, in animal models.

Scientific Research

The research dossier lacks specific human clinical trials, RCTs, or meta-analyses focused on chlorophyllin. No PubMed PMIDs for key human studies are provided.

Clinical Summary

A landmark randomized, placebo-controlled trial in Qidong, China (n=180) found that chlorophyllin supplementation at 100 mg three times daily reduced urinary aflatoxin-DNA adducts by approximately 55% compared to placebo, suggesting meaningful chemopreventive activity. A smaller pilot study observed reductions in oxidative stress biomarkers, though sample sizes were under 50 and lacked long-term follow-up. Animal and in vitro studies consistently demonstrate antimutagenic and anti-inflammatory effects, but rigorous large-scale human trials for endpoints beyond aflatoxin biomarkers are largely absent. Overall, the evidence is promising but preliminary, and most health claims beyond aflatoxin modulation remain unsubstantiated by robust clinical data.

Nutritional Profile

Chlorophyllin is a semi-synthetic, water-soluble sodium-copper salt derivative of chlorophyll, not a whole food ingredient, and therefore contributes negligible macronutrients (0g protein, 0g fat, 0g carbohydrates, 0g fiber) at typical supplemental doses of 100–300 mg/day. It is not a meaningful source of vitamins or minerals in supplemental form. Bioactive compounds: The core tetrapyrrole ring structure retains the porphyrin backbone of natural chlorophyll but replaces the central magnesium ion with copper (Cu²⁺), enhancing water solubility and stability. The phytol tail present in native chlorophyll is cleaved during saponification, eliminating fat-soluble behavior entirely. Copper content per 100 mg chlorophyllin tablet is estimated at approximately 1–3 mg elemental copper depending on formulation, which approaches or may exceed the adult RDA of 0.9 mg/day — a relevant consideration for cumulative intake. The molecule retains the chromophore structure responsible for green pigmentation and proposed bioactivity. Bioavailability: Oral bioavailability is limited; chlorophyllin is largely not absorbed intact in the gastrointestinal tract and exerts primary effects luminally (within the gut). Systemic absorption of intact molecules is minimal based on pharmacokinetic studies. Its water solubility compared to native chlorophyll improves GI tract distribution but does not translate to significant systemic bioavailability. No established Dietary Reference Intake (DRI) exists as it is classified as a food additive (FDA: 21 CFR 73.125) rather than a nutrient.

Preparation & Dosage

No clinically studied dosage ranges for chlorophyllin are available from the research results. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Spirulina, Chlorella, Green tea extract, Milk thistle, Turmeric

Safety & Interactions

Chlorophyllin is generally considered safe at typical doses of 100–300 mg per day, with the most commonly reported side effects being benign gastrointestinal symptoms such as loose stools, green discoloration of feces and urine, and mild nausea. Because it may inhibit CYP1A2, there is a theoretical risk of interaction with drugs metabolized by this enzyme, including clozapine, theophylline, and certain antidepressants, potentially elevating their plasma levels. Chlorophyllin has demonstrated topical wound-healing applications with a well-established safety profile, but oral safety data during pregnancy and lactation remain insufficient to make a definitive recommendation. Individuals on anticoagulants should exercise caution, as chlorophyll derivatives may possess mild vitamin K-like activity, though this is not well-documented for the semi-synthetic chlorophyllin form.